Find News

Filter articles

Showing 1 to 10 of 3377 results

Shionogi and Duchesnay add new patents to Osphena dispute

US05-08-2021Alex Baldwin

Pharmaceutical companies Shionogi and Duchesnay have filed a second lawsuit against Hetero labs, claiming that the company infringed two additional patents related to Osphena—a treatment for vaginal pain during sex.

Takeda faces ‘pay-for-delay’ class-action suit over anti-constipation drug

US05-08-2021Alex Baldwin

Takeda Pharmaceuticals is the target of a proposed class action that alleges the pharma giant paid to keep a generic anti-constipation drug off the market.

FTC urges Congress to step in over AbbVie antitrust claim

US03-08-2021Muireann Bolger

The US Federal Trade Commission has dropped its remaining claim in a lawsuit against AbbVie and Besins Healthcare, after the US Supreme Court declined to rule that consumers had a right to be compensated by the companies.

US Judiciary Committee advances four bills to curb antitrust pharma practices

US03-08-2021Mergers & acquisitionsAlex Baldwin

The US Senate Judiciary Committee has unanimously voted to pass four bills that aim to crack down on anti-competitive practices in the pharmaceutical industry.

Is big pharma’s antidote to the COVID-19 waiver a viable alternative?

29-07-2021Alex Baldwin

In May, a consortium of pharmaceutical companies came together to pitch a new plan to help provide more equitable access to COVID-19 vaccines.

Bio-Rad and 10X Genomics end patent fight with new licensing deal

US29-07-2021Muireann Bolger

Bio-Rad Laboratories has settled its long-running dispute with 10X Genomics over patents covering genetic analysis tech and both companies have negotiated an agreement to cross-license their products.

FDA approves milestone biosimilar insulin drug


The US Food and Drug Administration has approved the first-ever interchangeable biosimilar product, an insulin treatment for Types 1 and 2 diabetes.

New York judge denies arbitration request in $881m cannabinoid suit

US27-07-2021Alex Baldwin

A New York federal court has denied biotechnology company Amyris’ bid for arbitration in an $881 million trade secrets and patent infringement dispute with cannabis firm Lavvan.

Judge cuts ‘disproportionate’ £1.7m costs claim by Roche

US27-07-2021Legal developmentsMuireann bolger

Roche has drawn criticism from an English High Court judge over its ‘disproportionate” demand for nearly $2.3m in costs, after it won a patent dispute with medical device company Insulet over a tubeless insulin pump.

Novartis told to pay $178m over infringing cancer drug

US26-07-2021Rory O' Neill

A California jury has ordered Novartis to pay $178 million to rival drugmaker Daiichi Sankyo for willfully infringing two cancer drug patents.

Showing 1 to 10 of 3377 results